Indocyanine green assisted retinal internal limiting membrane removal in stage 3 or 4 macular hole surgery
- PMID: 12488266
- PMCID: PMC1771454
- DOI: 10.1136/bjo.87.1.71
Indocyanine green assisted retinal internal limiting membrane removal in stage 3 or 4 macular hole surgery
Abstract
Aims: To determine surgical outcome in primary idiopathic stage 3 or 4 macular holes with indocyanine green (ICG) assisted retinal internal limiting membrane (ILM) peeling.
Methods: A prospective, consecutive, interventional case series with 41 eyes of 40 patients was included. No patient defaulted follow up. Besides a standard macular hole surgery, all eyes received ICG assisted ILM removal of 3-4 disc diameters around macular holes. At the end of the surgery, 12% perfluoropropane gas was used. A face down posture for 2 weeks was required postoperatively.
Results: The mean follow up period was 15.1 months (range 6-24 months). Twenty (48.8%) eyes had stage 3 macular holes and 21 (51.2%) had stage 4 macular holes. The overall median duration of holes was 11 months. 19 (46.3%) were chronic macular holes of more than 12 months' duration. The anatomical success rates after one surgery was 87.8% (36 eyes), while that of chronic and non-chronic ones was 78.9% and 95.5%, respectively. The median preoperative and postoperative visual acuity was 20/200 (range 20/60 to counting fingers) and 20/100 (range 20/20 to 20/400), respectively. 24 (58.5%) eyes had improvement of two or more Snellen lines. The mean was 3.2 lines (range two to nine lines), with 3.6 lines and 2.7 lines for non-chronic and chronic holes, respectively. For all the 41 eyes, 16 (39%) eyes had a final visual acuity of 20/50 or better.
Conclusion: ICG assisted retinal ILM removal, in idiopathic primary chronic and non-chronic stage 3 or 4 macular hole surgery, appears to give a promising anatomical closure rate without compromising the visual result.
Similar articles
-
Clinical findings in macular hole surgery with indocyanine green-assisted peeling of the internal limiting membrane.Graefes Arch Clin Exp Ophthalmol. 2003 Jul;241(7):589-592. doi: 10.1007/s00417-003-0673-1. Epub 2003 May 8. Graefes Arch Clin Exp Ophthalmol. 2003. PMID: 12736727
-
Long-term follow-up of indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for idiopathic macular hole repair.Ophthalmology. 2004 Dec;111(12):2246-53. doi: 10.1016/j.ophtha.2004.05.037. Ophthalmology. 2004. PMID: 15582081
-
Internal limiting membrane removal in macular hole surgery for severely myopic eyes: a case-control study.Br J Ophthalmol. 2003 Jul;87(7):885-9. doi: 10.1136/bjo.87.7.885. Br J Ophthalmol. 2003. PMID: 12812892 Free PMC article.
-
Internal limiting membrane removal in the management of full-thickness macular holes.Am J Ophthalmol. 2000 Jun;129(6):769-77. doi: 10.1016/s0002-9394(00)00358-5. Am J Ophthalmol. 2000. PMID: 10926987 Review.
-
Macular hole surgery in 2000.Curr Opin Ophthalmol. 2000 Jun;11(3):186-90. doi: 10.1097/00055735-200006000-00006. Curr Opin Ophthalmol. 2000. PMID: 10977225 Review.
Cited by
-
Macular function and morphology after peeling of idiopathic epiretinal membrane with and without the assistance of indocyanine green.Br J Ophthalmol. 2005 Apr;89(4):437-43. doi: 10.1136/bjo.2004.051250. Br J Ophthalmol. 2005. PMID: 15774920 Free PMC article.
-
Effects of Indocyanine green on cultured retinal ganglion cells in-vitro.BMC Res Notes. 2009 Nov 25;2:236. doi: 10.1186/1756-0500-2-236. BMC Res Notes. 2009. PMID: 19939252 Free PMC article.
-
[Statement of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on the development, diagnostics and treatment of epiretinal gliosis : Status October 2020].Ophthalmologe. 2021 Feb;118(2):121-138. doi: 10.1007/s00347-020-01291-3. Ophthalmologe. 2021. PMID: 33346894 Review. German. No abstract available.
-
Vitrectomy and gas tamponade without internal limiting membrane peeling for myopic foveoschisis.Br J Ophthalmol. 2005 Sep;89(9):1180-3. doi: 10.1136/bjo.2005.069427. Br J Ophthalmol. 2005. PMID: 16113377 Free PMC article.
-
Analysis of retinal alterations utilizing intraoperative OCT following surgical interventions with novel ILM forceps in the DISCOVER study.Sci Rep. 2024 Jul 23;14(1):16959. doi: 10.1038/s41598-024-67700-8. Sci Rep. 2024. PMID: 39043729 Free PMC article.
References
-
- Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol 1991;109:654–9. - PubMed
-
- Wendel RT, Patel AC, Kelly NE, et al. Vitreous surgery for macular holes. Ophthalmology 1993;100:1671–6. - PubMed
-
- 1. Freeman WR, Azen SP, Kim JW, et al. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group. Arch Ophthalmol 1997;115:11–21. - PubMed
-
- 2. Glaser BM, Michels RG, Kuppermann BD, et al. Transforming growth factor-β2 for the treatment of full-thickness macular holes: a prospective randomized study. Ophthalmology 1992;99:1162–72. - PubMed
-
- Lansing MB, Glaser BM, Liss H, et al. The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes. Ophthalmology 1993;100:868–71. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources